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Background
Genetic profiling by RNA microarray of normal and
neoplastic colonic tissue is used to identify biomarkers
for development of a diagnostic tool for the inherited
colon cancer syndromes. The utility of this method is to
1) properly classify patients where genetic diagnosis is
incomplete 2) suggest molecular pathways that are
shared between the syndromes and 3) identify molecular
targets for prevention and treatment.
Methods
RNA was extracted from fresh colonic biopsies obtained
during endoscopy. Agilent 44K whole genome microar-
rays were run on 7-10 normal and neoplastic sample
pairs from control, FAP, AFAP, Cowden syndrome,
hyperplastic polyposis (HPP), and HNPCC (normal tis-
sue only) patients. Microarray data were normalized,
log-transformed, and analyzed for > 1.2 fold differential
expression using GeneSifter software with a t-test
adjusted by the Benjamini and Hochberg method. The
most significant 100 mRNA probes were selected for
evaluation. Select genes were confirmed by real-time
quantitative PCR. Pathway analysis was done using prior
knowledge resources including Genespring, KEGG and
Cytoscape with microarray derived models.
Results
The most significant 100 of 44,000 probes gave adjusted
p-values < 3x10
-4. Within this subset, the mRNAs from
causative genes are decreased in normal colonic tissue
from Cowden syndrome (PTEN), HNPCC (MLH1), and
AFAP (APC) patients, but not from FAP (APC) patients,
suggesting the presence of unstable mRNA and a molecu-
lar level of haploinsufficiency. The largest increased
expression in HNPCC vs. controls included three genes
with plekstrin homology domains (TRIOBP, PLEKHF1,
FGD1), and two of these are also increased in Cowden
syndrome (PLEKHF1, FGD1)a l o n gw i t hSMAD5.T h e r e
appear to be parallels between FAP and HPP. Normal
H P Pt i s s u eh a sad e c r e a s ei nNKD2 which is a negative
regulator of the canonical WNT signaling pathway.
Normal FAP (vs. control) and HPP polyp (vs. normal)
demonstrate a disruption in MEKK4 (MAP3K4)-ANXA2-
PLG-MMP7 pathways. Additionally the proto-oncogene,
MET, is up-regulated in FAP and AFAP normal as well as
HPP polyp tissues. MET is a tyrosine kinase HGF recep-
tor; mutations are associated with hereditary papillary
renal carcinoma and it resides in a genetic region asso-
ciated with common familial colon cancer. This gene may
have a central role in predisposing cells for a proliferative
phenotype as it interacts with beta-catenin pathway.
Conclusions
Deciphering the molecular signatures of the inherited
colon cancer syndromes has revealed, and will continue
to reveal, interesting clues into pathways that are differ-
entially regulated in normal colonic tissue, and those are
altered during the neoplastic process.
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